Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/176723
Role of colchicine treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): real-life data from the AIDA Network
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Objective: To analyze the potential role of colchicine monotherapy in patients with tumor necrosis factor receptor associated periodic syndrome (TRAPS) in terms of control of clinical and laboratory manifestations. Methods: Patients with TRAPS treated with colchicine monotherapy were retrospectively enrolled; demographic, clinical and therapeutic data were collected and statistically analysed after having clustered patients according to different times at disease onset, penetrance of mutations, dosage of colchicine, and different disease manifestations. Results: 24 patients (14 males; 15 with pediatric disease onset) treated with colchicine monotherapy were enrolled. Colchicine resulted in a complete response in 3 (12.5%) cases, partial response in 14 (58.3%) patients, and lack of response in 7 (29.2%) patients. There were not significant differences in colchicine response between pediatric and adult disease onset (p = 0.42), between low- and high-penetrance mutations (p = 0.62), and according to different dosages (p = 0.66). No significant differences were identified in the frequency of specific disease manifestations between patients experiencing any response to colchicine and patients with lack of response. Conclusions: Colchicine monotherapy is useful in a low percentage of TRAPS patients; nevertheless, it could be attempted in patients with milder phenotypes and at a lower risk of developing reactive amyloidosis.
Matèries
Matèries (anglès)
Citació
Citació
VITALE, Antonio, SOTA, Jurgen, OBICI, Laura, RICCO, Nicola, MAGGIO, Maria cristina, CATTALINI, Marco, RUSCITTI, Piero, CASO, Francesco, MANNA, Raffaele, VIAPIANA, Ombretta, CAGGIANO, Valeria, EMMI, Giacomo, INSALACO, Antonella, MONTIN, Davide, LICCIARDI, F.rancesco, SORIANO, Alessandra, DAGNA, Lorenzo, SALVARANI, Carlo, LAMACCHIA, Vittoria, HERNÁNDEZ RODRÍGUEZ, José, GIACOMELLI, Roberto, FREDIANI, Bruno, RENIERI, Alessandra, CANTARINI, Luca. Role of colchicine treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): real-life data from the AIDA Network. _Mediators of Inflammation_. 2020. Vol. 2020, núm. 1936960. [consulta: 29 de gener de 2026]. ISSN: 0962-9351. [Disponible a: https://hdl.handle.net/2445/176723]